20.927 articles found

Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.

Rupniak NM, Tye SJ, Jennings CA, Loper AE, Bondi JV, Hichens M, Iversen SD, Stahl SM.

J Neurol Neurosurg Psychiatry · 1989-02-01

DOI: 10.1136/jnnp.52.2.289PMID: 2703851

Piribedil therapy in Parkinson's disease. Use of the drug in the retard form.

Mentenopoulos G, Katsarou Z, Bostantjopoulou S, Logothetis J.

Clin Neuropharmacol · 1989-02-01

PMID: 2713865

A strategy for measuring the therapeutic properties of new antiparkinsonian drugs, such as +PHNO, in patients with on-off fluctuations.

Coleman RJ, Temlett JA, Quinn NP, Stahl SM, Marsden CD.

Clin Neuropharmacol · 1989-02-01

DOI: 10.1097/00002826-198902000-00005PMID: 2565765

Levodopa and 3-O-methyldopa plasma levels in parkinsonian patients with stable and fluctuating motor response.

Luquin MR, Vaamonde J, Obeso JA.

Clin Neuropharmacol · 1989-02-01

DOI: 10.1097/00002826-198902000-00006PMID: 2713867

Increased dosage of carbidopa in parkinsonian patients on low carbidopa-levodopa regimen. Effect on levodopa bioavailability.

Contin M, Riva R, Martinelli P, Procaccianti G, Baruzzi A.

Clin Neuropharmacol · 1989-02-01

DOI: 10.1097/00002826-198902000-00010PMID: 2713868

The fate of levodopa in rats and man

Wood ND.

· 1989-01-01

Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease.

Birkmayer W, Birkmayer GJ.

Ann Clin Lab Sci · 1989-01-01

PMID: 2644889

Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine.

Kempster PA, Lees AJ, Crichton P, Frankel JP, Shorvon P.

Mov Disord · 1989-01-01

DOI: 10.1002/mds.870040108PMID: 2927402

Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations.

Kempster PA, Gibb WR, Stern GM, Lees AJ.

J Neurol Neurosurg Psychiatry · 1989-01-01

DOI: 10.1136/jnnp.52.1.72PMID: 2709038

Second interim report of the nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.

Nakanishi T, Iwata M, Goto I, Kanazawa I, Kowa H, Mannen T, Mizuno Y, Nishitani H, Ogawa N, Takahashi A.

Eur Neurol · 1989-01-01

DOI: 10.1159/000116446PMID: 2714305

[Movement patterns of demented and non-demented nursing home patients using the Involuntary Movements and Extrapyramidal Scale. Effects of pharmacotherapy].

Schönenberger PM, Noser A, Christinat S, Wettstein A.

Schweiz Arch Neurol Psychiatr (1985) · 1989-01-01

PMID: 2470143

Should levodopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 parkinsonian patients treated with levodopa over 14 years.

Indo T, Takahashi A.

Jpn J Med · 1989-01-01

DOI: 10.2169/internalmedicine1962.28.30PMID: 2724644